BRN (ASX) Technology due diligence

Originally posted by trothlis: ↑

I discovered Brainchip from the articles on EETimes in September 2018 and after doing a little bit of research I decided that they appeared to be legit and made a small investment. With the stock now on my radar, the recent performance has led me to dig deeper; to figure out whether I was duped or if this is an opportunity to buy more. So I'm interested in hearing your thoughts on some observations I've put together after doing a bit more research. This appears to be the only place where people are regularly discussing Brainchip. For background, I am an engineer in the US who is familiar with FPGAs, but I'm not an expert in neural networks.

Observation #1 - Milestone 2 in October 2015 implemented the SNAP64 architecture on a Dini Group board with multiple Xilinx Virtex-7 2000T FPGAs. This board is probably the DNV7F4A containing four chips. This provides a total of nearly 8 million logic cells at full utilization (where each logic cell is the equivalent of a 4-input look-up table and a flip-flop). We're told that SNAP64 implements 64 neurons with 256 synapses each. If we assume a generous 90% utilization on the FPGAs for just the SNN fabric, this equates to about 112500 logic cells per neuron. Each synapse has its own temporal integrator, STDP function, a neurotransmitter function, a neuromodulator function, a strength function, a slope function and a duration function. If we assume something like 10000 logic cells for the post-synaptic logic (delays, dendrite integration, soma integration, and spike shaping) then we're left with about 400 logic cells per synapse. Note that this is ignoring the "connectome" (the logic to route the trained network according to the training results) and all other supporting logic. These certainly chew up a fair bit of space and overall makes the 90% utilization a very optimistic estimate. So, while it seems plausible to implement this on the DNV7F4A board, I feel like I have to be very generous and optimistic to make it work. It would be illuminating to get details on the utilization for this implementation.

Observation #2 - The Akida NSoC is claimed to support 1.2 million neurons and 10 billion synapses (though this is sometimes qualified as an "effective" quantity), and has been given a price target of $10 - $15 (in volume). If this is literal, it's ludicrous. While it is certainly true that there are a lot of gains to be made moving from an FPGA to an ASIC, I can't see how they can produce an ASIC with 75000 times the number of neurons compared to the implementation achieved on a single Virtex-7 2000T FPGA (assuming 16 neurons per FPGA in the milestone, and ignoring that larger network should have more synapses per neuron). They're using "pure CMOS logic", so there's no special analog circuit that replaces a bunch of transistors. The largest ASIC (per Wikipedia) is 23.6 billion transistors (the G2C IPU). Even if there were only 3 transistors per synapse, Akida would become the chip with the most transistors. If we take these numbers literally, we're talking about TRILLIONS of transistors. Furthermore, it seems impossible that this could cost anything close to $10 - $15 and consume less than 1W (with a 28nm process, no less). The chip would be substantially far more complex than the 2000T FPGA, which costs thousands of dollars and consumes dozens of watts for a design like this. The numbers have to be wrong somewhere. The only way I can make sense of this is if the 1.2M neurons and 10B synapses are not literal and "effectively" represent what would be required by implementations in traditional processor technology to achieve equivalent throughput. This is by far the observation that I'm struggling with the most, and I would really like to see an explanation.

Observation #3 - The Brainchip Accelerator is clearly an off-the-shelf board (Alpha Data ADM-PCIE-8K5) with a custom FPGA program implementing the SNN. The FPGA on this board provides 1.45 million logic cells. Per the estimates from Milestone 2 above it would support no more than 13 neurons with 256 synapses each - but there are probably fewer synapses if there are also fewer total neurons, so it might be something more like 24 neurons with 128 synapses each. What's also interesting is that the off-the-shelf nature of the hardware is not disclosed anywhere and the branding on the board is intentionally erased in the images from Brainchip. There's nothing wrong with buying an off-the-shelf board, loading a custom image to it, and reselling it as something else, so I don't know why they would hide this. It's also possible that the existence of this board could be seen as a testament to the scalability of the architecture in that they were able to get something functional by scaling down from the design that was used in Milestone 2.

Finally, though these observations are generally negative, I don't want to leave the impression that I think this company is a sham. In this process I've also discovered a long history of progress. I like to think that the neuron architecture makes sense. There's strong evidence that many personnel are well qualified, and of collaborations with legitimate professionals and researchers. As much as the observations above bother me, I also can't dismiss all the signs that there is a real technology being developed here that is a game changer if they can see it through.So does anybody have any thoughts on these observations?

Expand

It's a pleasure having someone with your background and (questioning) appreciation of SNN's in our group. Welcome to the mad house.

Long story short, I generally agree with the suggestion made by jtard that perhaps the Company is the best place to seek answers to your questions. But in saying that, the details you're seeking go right to the proprietory heart of the IP built into the neural fabric for both FPGA's as well as IC. And as you have probably heard many times from LDN, it's critical that the Co keeps it's secrets and inventions under wraps. So beyond details contained in published Patents and Applications you're probably unlikely to get much more information from PVDM anyway.

I know it comes across like a cop out from the Company and hey you have good reason to be annoyed because it represents a fence hindering the validation of the tech.

But good questions though and lots of luck.

No.	Vol.	Price($)
5	153202	25.5¢

No.

Vol.

Price($)

153202

25.5¢

Price($)	Vol.	No.
26.0¢	582424	11

Price($)

Vol.

No.

26.0¢

582424

No.	Vol.	Price($)
4	114498	0.160
57	2292028	0.155
123	4077489	0.150
37	921712	0.145
43	1157536	0.140

No.

Vol.

Price($)

114498

0.160

2292028

0.155

123

4077489

0.150

921712

0.145

1157536

0.140

Price($)	Vol.	No.
0.165	1334406	26
0.170	1214183	25
0.175	1065244	14
0.180	1447476	19
0.185	684576	22

Price($)

Vol.

No.

0.165

1334406

0.170

1214183

0.175

1065244

0.180

1447476

0.185

684576

(20min delay)
Last 25.5¢		Change -0.015(5.56%)		Mkt cap ! $323.8M

Open	High	Low	Value	Volume
26.5¢	26.5¢	25.0¢	$1.950M	7.634M

Technology due diligence, page-9

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Buyers (Bids)

Sellers (Offers)

Technology due diligence, page-9

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Buyers (Bids)

Sellers (Offers)